Galapagos NV
GLPG
#5081
Rank
NZ$3.26 B
Marketcap
NZ$48.58
Share price
0.00%
Change (1 day)
3.45%
Change (1 year)

EPS for Galapagos NV (GLPG)

EPS in 2026 (TTM): NZ-$0.93

According to Galapagos NV's latest financial reports the company's current EPS (TTM) is NZ-$0.71. In 2025 the company made an earnings per share (EPS) of NZ$10.02 an increase over its 2024 EPS that were of NZ$2.04.

EPS history for Galapagos NV from 2004 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$0.93-109.24%
2025NZ$10.02390.86%
2024NZ$2.04-67.16%
2023NZ$6.22-199.64%
2022NZ-$6.2499.03%
2021NZ-$3.13-68.98%
2020NZ-$10.11-298.06%
2019NZ$5.10-554.64%
2018NZ-$1.12-77.18%
2017NZ-$4.92-326.21%
2016NZ$2.17-134.19%
2015NZ-$6.36-371.34%
2014NZ$2.34-445.98%
2013NZ-$0.6832.88%
2012NZ-$0.51-82.07%
2011NZ-$2.84-817.9%
2010NZ$0.4012.73%
2009NZ$0.35-120.79%
2008NZ-$1.69-37.67%
2007NZ-$2.7139.64%
2006NZ-$1.9428.17%
2005NZ-$1.516.25%
2004NZ-$1.43

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$15.30-2,244.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$6.32-985.84%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$3.60-604.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$4.48-728.35%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
NZ$6.23-973.26%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$12.18-1,806.09%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
NZ$6.81-1,054.01%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
NZ-$1.07 49.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$2.40-436.31%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel